Mr. O’Day currently serves as chief executive officer for Roche’s Pharmaceutical Division and a member of the Roche corporate executive committee. Mr. O’Day has nearly three decades of operating expertise at Roche having served previously in various executive leadership positions for Roche Pharmaceuticals and Diagnostics. Previously, Mr. O’Day served as president and chief operating officer of Roche Molecular Diagnostics USA and subsequently, chief operating officer of Roche’s Pharmaceutical Division. Mr. O’Day received a B.S. degree in biology from Georgetown University and a master’s degree in business administration from Columbia University.